APLM
Price
$14.74
Change
+$0.90 (+6.50%)
Updated
Dec 4, 04:54 PM (EDT)
Capitalization
29.66M
Intraday BUY SELL Signals
RVMD
Price
$78.50
Change
+$0.81 (+1.04%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
15.02B
88 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

APLM vs RVMD

Header iconAPLM vs RVMD Comparison
Open Charts APLM vs RVMDBanner chart's image
Apollomics
Price$14.74
Change+$0.90 (+6.50%)
Volume$100
Capitalization29.66M
Revolution Medicines
Price$78.50
Change+$0.81 (+1.04%)
Volume$28.21K
Capitalization15.02B
APLM vs RVMD Comparison Chart in %
APLM
Daily Signal:
Gain/Loss:
RVMD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
APLM vs. RVMD commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLM is a StrongBuy and RVMD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 05, 2025
Stock price -- (APLM: $13.84 vs. RVMD: $77.69)
Brand notoriety: APLM and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLM: 39% vs. RVMD: 136%
Market capitalization -- APLM: $29.66M vs. RVMD: $15.02B
APLM [@Biotechnology] is valued at $29.66M. RVMD’s [@Biotechnology] market capitalization is $15.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLM’s FA Score shows that 0 FA rating(s) are green whileRVMD’s FA Score has 0 green FA rating(s).

  • APLM’s FA Score: 0 green, 5 red.
  • RVMD’s FA Score: 0 green, 5 red.
According to our system of comparison, both APLM and RVMD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLM’s TA Score shows that 2 TA indicator(s) are bullish while RVMD’s TA Score has 2 bullish TA indicator(s).

  • APLM’s TA Score: 2 bullish, 6 bearish.
  • RVMD’s TA Score: 2 bullish, 2 bearish.
According to our system of comparison, RVMD is a better buy in the short-term than APLM.

Price Growth

APLM (@Biotechnology) experienced а -9.19% price change this week, while RVMD (@Biotechnology) price change was +0.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.21%. For the same industry, the average monthly price growth was +5.86%, and the average quarterly price growth was +56.03%.

Reported Earning Dates

RVMD is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+1.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($15B) has a higher market cap than APLM($29.7M). RVMD YTD gains are higher at: 77.618 vs. APLM (41.949). APLM has higher annual earnings (EBITDA): -56.38M vs. RVMD (-883.71M). APLM has less debt than RVMD: APLM (4.72M) vs RVMD (133M). APLM (0) and RVMD (0) have equivalent revenues.
APLMRVMDAPLM / RVMD
Capitalization29.7M15B0%
EBITDA-56.38M-883.71M6%
Gain YTD41.94977.61854%
P/E RatioN/AN/A-
Revenue00-
Total CashN/A2.14B-
Total Debt4.72M133M4%
TECHNICAL ANALYSIS
Technical Analysis
APLMRVMD
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
56%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
67%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
49%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 21 days ago
76%
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 15 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
71%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
APLM
Daily Signal:
Gain/Loss:
RVMD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DBEZ54.910.13
+0.23%
Xtrackers MSCI Eurozone Hedged Eq ETF
BUFD28.080.04
+0.14%
FT Vest Laddered Deep Buffer ETF
IBHI23.620.02
+0.06%
iShares iBonds 2029 Term HY & Inc ETF
RNWZ27.38N/A
N/A
TrueShares Eagle Glbl Rnwbls Engy IncETF
MHNC16.37-0.28
-1.68%
MAIDEN HOLDINGS NORTH AMERICA Ltd

APLM and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLM has been loosely correlated with SNTI. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if APLM jumps, then SNTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLM
1D Price
Change %
APLM100%
-0.43%
SNTI - APLM
47%
Loosely correlated
+4.76%
MGX - APLM
37%
Loosely correlated
+13.83%
IPHA - APLM
36%
Loosely correlated
-2.56%
QSI - APLM
34%
Loosely correlated
+7.09%
RVMD - APLM
33%
Loosely correlated
+3.16%
More

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with NUVL. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
+3.16%
NUVL - RVMD
60%
Loosely correlated
+1.85%
IRON - RVMD
54%
Loosely correlated
+2.96%
CGON - RVMD
53%
Loosely correlated
+3.00%
CLDX - RVMD
53%
Loosely correlated
+4.27%
ROIV - RVMD
52%
Loosely correlated
+2.99%
More